Skip to main content
main-content

Latest news

Free registration

Medicine Matters is developed for healthcare professionals as

a premier resource for the latest clinical information in medicine.

Young-onset type 2 diabetes: A different process?

Overweight woman at doctor's (symbolic image with models)

Escalating obesity prevalence and severity has led to type 2 diabetes being diagnosed in ever-younger people, including children. medwireNews rounds up the accumulating evidence suggesting a particularly severe diabetes course in these young people.

Periconceptional HbA1c levels ‘strongly linked’ to preterm birth risk

Pregnant woman_doctor with clipboard

The risk for preterm birth among women with type 1 diabetes increases considerably with increasing glycated hemoglobin levels around the time of conception, study findings indicate.

Latest headlines

04-24-2019 | Pregnancy | Highlight | News

Periconceptional HbA1c levels ‘strongly linked’ to preterm birth risk

The risk for preterm birth among women with type 1 diabetes increases considerably with increasing glycated hemoglobin levels around the time of conception, study findings indicate.

04-23-2019 | Metformin | News

Metformin may help people at high diabetes risk to maintain weight loss

Fifteen years of follow-up of the DPP trial shows that although people initially lost more weight with the intensive lifestyle intervention, those assigned to metformin did better at keeping the weight off in the long term.

04-18-2019 | Risk factors | News

Study bolsters evidence for 5 alpha-reductase inhibitor link to type 2 diabetes

Men with benign prostatic hyperplasia undergoing long-term treatment with 5α-reductase inhibitors are significantly more likely to develop type 2 diabetes than those receiving the α-blocker tamsulosin, population-based study data show.

Features and expert interviews

04-24-2019 | Type 2 diabetes | Feature | Article

Young-onset type 2 diabetes: A different process?

Escalating obesity prevalence and severity has led to type 2 diabetes being diagnosed in ever-younger people, including children. medwireNews rounds up the accumulating evidence suggesting a particularly severe diabetes course in these young people.

04-17-2019 | Nephropathy | Podcast | Article

Nephrologist expert commentary: The CREDENCE trial

Consultant nephrologist Andrew Frankel tells medwireNews about the rationale and key findings of the CREDENCE trial, and discusses the potential benefits of SGLT2 inhibitors beyond type 2 diabetes (9:45).

04-17-2019 | Nephropathy | Podcast | Article

Primary care expert commentary: The CREDENCE trial

General practitioner Kevin Fernando talks to medwireNews about the importance of the CREDENCE trial from a primary care perspective (4:43).

image credits